FR2204421A1 - - Google Patents

Info

Publication number
FR2204421A1
FR2204421A1 FR7338282A FR7338282A FR2204421A1 FR 2204421 A1 FR2204421 A1 FR 2204421A1 FR 7338282 A FR7338282 A FR 7338282A FR 7338282 A FR7338282 A FR 7338282A FR 2204421 A1 FR2204421 A1 FR 2204421A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7338282A
Other languages
French (fr)
Other versions
FR2204421B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2204421A1 publication Critical patent/FR2204421A1/fr
Application granted granted Critical
Publication of FR2204421B1 publication Critical patent/FR2204421B1/fr
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7338282A 1972-10-27 1973-10-26 Expired FR2204421B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10777672A JPS5443570B2 (en) 1972-10-27 1972-10-27

Publications (2)

Publication Number Publication Date
FR2204421A1 true FR2204421A1 (en) 1974-05-24
FR2204421B1 FR2204421B1 (en) 1977-09-09

Family

ID=14467713

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7338282A Expired FR2204421B1 (en) 1972-10-27 1973-10-26

Country Status (4)

Country Link
JP (1) JPS5443570B2 (en)
DE (1) DE2353797A1 (en)
FR (1) FR2204421B1 (en)
GB (1) GB1450960A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2441389A1 (en) * 1978-11-20 1980-06-13 Chinoin Gyogyszer Es Vegyeszet CYCLODEXTRIN-CAMOMILE INCLUSION COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SUCH COMPLEXES
EP0399902A1 (en) * 1989-05-24 1990-11-28 Rhone-Poulenc Sante Porous pharmaceutical form and process to prepare it

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS536416A (en) * 1976-07-01 1978-01-20 Emu Esu Shii Yuugen 55fluorouracli inclusion compound
JPS53133623A (en) * 1977-04-21 1978-11-21 Fujimoto Seiyaku Kk Medical preparation including antiicholine active medicine by cyclodextrin analogue
DE3162914D1 (en) * 1981-01-10 1984-05-10 Chinoin Gyogyszer Es Vegyeszet Stabilized prostaglandin tablets for topical use with regulated dissolving speed and process for preparing them
JPS5830032B2 (en) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 Bifidus bacteria growth agent
DE3304864A1 (en) * 1983-02-12 1984-08-16 Bayer Ag, 5090 Leverkusen Adsorbates of prostaglandins
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
HU196306B (en) * 1985-04-01 1988-11-28 Chinoin Gyogyszer Es Vegyeszet New dusting powders comprising bioactive material and process for preparing the same
JPH075464B2 (en) * 1985-07-08 1995-01-25 中外製薬株式会社 Stable nicorandil formulation
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US5684121A (en) * 1994-12-06 1997-11-04 Isp Investments Inc. N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
JPWO2006075690A1 (en) * 2005-01-14 2008-06-12 小野薬品工業株式会社 Stable pharmaceutical composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3504019A (en) * 1967-02-20 1970-03-31 American Home Prod Prostaglandin purification process
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
FR2100745A1 (en) * 1970-06-10 1972-03-24 Ono Pharmaceutical Co

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3504019A (en) * 1967-02-20 1970-03-31 American Home Prod Prostaglandin purification process
FR2100745A1 (en) * 1970-06-10 1972-03-24 Ono Pharmaceutical Co
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2441389A1 (en) * 1978-11-20 1980-06-13 Chinoin Gyogyszer Es Vegyeszet CYCLODEXTRIN-CAMOMILE INCLUSION COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SUCH COMPLEXES
EP0399902A1 (en) * 1989-05-24 1990-11-28 Rhone-Poulenc Sante Porous pharmaceutical form and process to prepare it
FR2647343A1 (en) * 1989-05-24 1990-11-30 Rhone Poulenc Sante NOVEL POROUS PHARMACEUTICAL FORM AND PREPARATION THEREOF

Also Published As

Publication number Publication date
JPS5443570B2 (en) 1979-12-20
FR2204421B1 (en) 1977-09-09
DE2353797A1 (en) 1974-05-09
JPS4966816A (en) 1974-06-28
GB1450960A (en) 1976-09-29

Similar Documents

Publication Publication Date Title
FR2194470A1 (en)
JPS4931415A (en)
FR2204421B1 (en)
JPS4964629A (en)
JPS4915352A (en)
JPS4972107A (en)
JPS49107817U (en)
JPS5239737Y2 (en)
JPS4896521U (en)
JPS4985261A (en)
JPS49105553U (en)
JPS48111185U (en)
JPS4943923U (en)
HU166131B (en)
CH1527273A4 (en)
CH577304A5 (en)
CH570116A5 (en)
CH569888A5 (en)
CH579689A5 (en)
CH577018A5 (en)
CH577270A5 (en)
CH567723A5 (en)
CH577405A5 (en)
CH578896B5 (en)
CH569133B5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse